I'm sure Novo Nordisk would survive even with slightly lower margins. Also what proportion of that $1,000 goes to the manufacturer? From what I understand vari

I'm sure Novo Nordisk would survive even with slightly lower margins. Also what proportion of that $1,000 goes to the manufacturer? From what I understand various middlemen and such get a significant proportion of that without providing any value? e.g. https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices https://www.ftc.gov/news-events/news/press-releases/2024/09/...